Journal of Medical Economics, Volume 24, Issue 1 (2021)

Browse this journal
Sample our Medicine, Dentistry, Nursing & Allied Health journals, sign in here to start your FREE access for 14 days

Journal of Medical Economics, Volume 24, Issue 1 (2021)

See all volumes and issues
Vol 27, 2024 Vol 26, 2023 Vol 25, 2022 Volume 24, 2021 Vol 23, 2020 Vol 22, 2019 Vol 21, 2018 Vol 20, 2017 Vol 19, 2016 Vol 18, 2015 Vol 17, 2014 Vol 16, 2013 Vol 15, 2012 Vol 14, 2011 Vol 13, 2010 Vol 12, 2009 Vol 11, 2008 Vol 10, 2007 Vol 9, 2006 Vol 8, 2005 Vol 7, 2004 Vol 6, 2003 Vol 5, 2002 Vol 4, 2001 Vol 3, 2000 Vol 2, 1999 Vol 1, 1998
Download citations Download PDFs

 

Article
Healthcare resource utilization and exacerbations in patients with chronic obstructive pulmonary disease treated with nebulized glycopyrrolate in the USA: a real-world data analysis
Xiaoli Niu, Victoria Divino, Sanjay Sharma, Mitch Dekoven, Vamshi Ruthwik Anupindi & Carole Dembek
Pages: 1-9
Published online: 24 Nov 2020
AbstractforHealthcare resource utilization and exacerbations in patients with chronic obstructive pulmonary disease treated with nebulized glycopyrrolate in the USA: a real-world data analysis | Full Text | References | PDF (1.5 MB) | EPUB | Supplemental
  • 2735 Views
  • 4 CrossRef citations
  • 0Altmetric
Open Access
Article
Healthcare resource utilization and costs for hip dislocation following primary total hip arthroplasty in the medicare population
Jack Mantel, Abhishek S. Chitnis, Jill Ruppenkamp, Chantal E. Holy & Juan Daccach
Pages: 10-18
Published online: 16 Dec 2020
AbstractforHealthcare resource utilization and costs for hip dislocation following primary total hip arthroplasty in the medicare population | Full Text | References | PDF (736.1 KB) | EPUB
  • 2183 Views
  • 2 CrossRef citations
  • 0Altmetric
Open Access
Article
A budget impact analysis of gilteritinib for the treatment of relapsed or refractory FLT3mut+ acute myeloid leukemia in a US health plan
Bhavik J. Pandya, Hongbo Yang, Cynthia Schmeichel, Cynthia Z. Qi & Manasee V. Shah
Pages: 19-28
Published online: 18 Dec 2020
AbstractforA budget impact analysis of gilteritinib for the treatment of relapsed or refractory FLT3mut+ acute myeloid leukemia in a US health plan | Full Text | References | PDF (1.2 MB) | EPUB | Supplemental
  • 4002 Views
  • 4 CrossRef citations
  • 0Altmetric
Open Access
Article
Cost-effectiveness of topical glycopyrronium tosylate for the treatment of primary axillary hyperhidrosis
Lisa M. Bloudek, Kristin Khalaf Gillard, Victor B. Nguyen & Stephanie Zone Klein
Pages: 29-37
Published online: 18 Dec 2020
AbstractforCost-effectiveness of topical glycopyrronium tosylate for the treatment of primary axillary hyperhidrosis | Full Text | References | PDF (1.1 MB) | EPUB | Supplemental
  • 2234 Views
  • 4 CrossRef citations
  • 0Altmetric
Open Access
Article
Evaluation of access to care issues in patients with breast cancer
Carolyn M. Brown, Kristin M. Richards, Yogesh Vohra, Chisom Kanu, Laura Stevens, Rahul Sasane, Sanjeev Balu & Barbara McAneny
Pages: 38-45
Published online: 16 Dec 2020
AbstractforEvaluation of access to care issues in patients with breast cancer | Full Text | References | PDF (673.7 KB) | EPUB
  • 2389 Views
  • 3 CrossRef citations
  • 0Altmetric
Open Access
Article
Identifying disability level in multiple sclerosis patients in a U.S.-based health plan claims database
Regina Berkovich, Edward Fox, Annette Okai, Yao Ding, Magdaliz Gorritz, Lauren Bartolome, Rolin L. Wade, Wendy Su, Kristen M. Johnson & Patricia Russo
Pages: 46-53
Published online: 18 Dec 2020
AbstractforIdentifying disability level in multiple sclerosis patients in a U.S.-based health plan claims database | Full Text | References | PDF (1.4 MB) | EPUB
  • 3530 Views
  • 6 CrossRef citations
  • 0Altmetric
Open Access
Article
Effect of direct oral feeding following minimally invasive esophagectomy on costs and quality of life
Madhuri Pattamatta, Laura F. C. Fransen, Annemarie C. P. Dolmans-Zwartjes, Grard A. P. Nieuwenhuijzen, Silvia M. A. A. Evers, Ewout A. Kouwenhoven, Marc J. van Det, Mickael Hiligsmann & Misha D. P. Luyer
Pages: 54-60
Published online: 18 Dec 2020
AbstractforEffect of direct oral feeding following minimally invasive esophagectomy on costs and quality of life | Full Text | References | PDF (1.1 MB) | EPUB | Supplemental
  • 2459 Views
  • 5 CrossRef citations
  • 0Altmetric
Open Access
Article
Economic modeling of reSET-O, a prescription digital therapeutic for patients with opioid use disorder
Weijia Wang, Nicole Gellings Lowe, Ali Jalali & Sean M. Murphy
Pages: 61-68
Published online: 17 Dec 2020
AbstractforEconomic modeling of reSET-O, a prescription digital therapeutic for patients with opioid use disorder | Full Text | References | PDF (874.5 KB) | EPUB
  • 6297 Views
  • 14 CrossRef citations
  • 0Altmetric
Open Access
Article
The health economic impact of varying levels of adherence to colorectal screening on providers and payers
Joanne M. Hathway, Lesley-Ann Miller-Wilson, Weiyu Yao, Ivar S. Jensen, Milton C. Weinstein & Philip D. Parks
Pages: 69-78
Published online: 10 May 2021
AbstractforThe health economic impact of varying levels of adherence to colorectal screening on providers and payers | Full Text | References | PDF (1 MB) | EPUB | Supplemental
  • 2401 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access
Article
A comparison of mixture cure fraction models to traditional parametric survival models in estimation of the cost-effectiveness of nivolumab for relapsed small cell lung cancer
Joshua A. Roth, Yong Yuan, Megan Othus, Mark Danese, Samuel Wagner, John R. Penrod & Scott D. Ramsey
Pages: 79-86
Published online: 11 Jan 2021
AbstractforA comparison of mixture cure fraction models to traditional parametric survival models in estimation of the cost-effectiveness of nivolumab for relapsed small cell lung cancer | Full Text | References | PDF (1.2 MB) | EPUB | Supplemental
  • 3208 Views
  • 5 CrossRef citations
  • 0Altmetric
Open Access
Article
Long-term cost-effectiveness of a disease management program for patients with atrial fibrillation compared to standard care – a multi-state survival model based on a randomized controlled trial
Lan Gao, Paul Scuffham, Jocasta Ball, Simon Stewart & Joshua Byrnes
Pages: 87-95
Published online: 06 Jan 2021
AbstractforLong-term cost-effectiveness of a disease management program for patients with atrial fibrillation compared to standard care – a multi-state survival model based on a randomized controlled trial | Full Text | References | PDF (1.9 MB) | EPUB | Supplemental
  • 2419 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access
Article
Benefits of fracture liaison services (FLS) in four Latin American countries: Brazil, Mexico, Colombia, and Argentina
Rima Aziziyeh, Javier Garcia Perlaza, Najma Saleem, Hannah Guiang, Kirk Szafranski & Rebecca K. McTavish
Pages: 96-102
Published online: 11 Jan 2021
AbstractforBenefits of fracture liaison services (FLS) in four Latin American countries: Brazil, Mexico, Colombia, and Argentina | Full Text | References | PDF (805.7 KB) | EPUB | Supplemental
  • 2193 Views
  • 6 CrossRef citations
  • 0Altmetric
Open Access
Article
Cost-effectiveness of valbenazine compared with deutetrabenazine for the treatment of tardive dyskinesia
Michael L. Ganz, Ameya Chavan, Rahul Dhanda, Michael Serbin & Charles Yonan
Pages: 103-113
Published online: 20 Jan 2021
AbstractforCost-effectiveness of valbenazine compared with deutetrabenazine for the treatment of tardive dyskinesia | Full Text | References | PDF (2 MB) | EPUB | Supplemental
  • 4811 Views
  • 3 CrossRef citations
  • 0Altmetric
Open Access
Article
Healthcare resource utilization and costs among patients with relapsed and/or refractory multiple myeloma treated with proteasome inhibitors in real-world clinical practice in Germany
Tilman Hans Steinmetz, Moushmi Singh, Andrea Lebioda, Leah Fink, Martina Schoehl, Achim Rieth, Sebastian Gonzalez-McQuire & Monika Engelhardt
Pages: 114-122
Published online: 18 Jan 2021
AbstractforHealthcare resource utilization and costs among patients with relapsed and/or refractory multiple myeloma treated with proteasome inhibitors in real-world clinical practice in Germany | Full Text | References | PDF (1.1 MB) | EPUB | Supplemental
  • 2867 Views
  • 6 CrossRef citations
  • 0Altmetric
Open Access
Article
Estimating the public economic consequences of cardiovascular disease-attributable events and evolocumab treatment in Australia
Nikolaos Kotsopoulos, Mark P. Connolly & Jinjing Li
Pages: 123-130
Published online: 19 Jan 2021
AbstractforEstimating the public economic consequences of cardiovascular disease-attributable events and evolocumab treatment in Australia | Full Text | References | PDF (978.9 KB) | EPUB | Supplemental
  • 1970 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access
Article
Budget impact of capmatinib for adults with metastatic non-small cell lung cancer harboring a MET exon 14 skipping mutation in the United States
Beilei Cai, Zheng-Yi Zhou, Weiguang Xue, Nisha C. Hazra, Mukesh Singh, Dinesh Mishra, Diana Brixner, Gary Oderda & Joseph Biskupiak
Pages: 131-139
Published online: 21 Jan 2021
AbstractforBudget impact of capmatinib for adults with metastatic non-small cell lung cancer harboring a MET exon 14 skipping mutation in the United States | Full Text | References | PDF (2.3 MB) | EPUB | Supplemental
  • 3847 Views
  • 7 CrossRef citations
  • 0Altmetric
Open Access
Article
Societal costs of primary progressive multiple sclerosis in Australia and the economic impact of a hypothetical disease-modifying treatment that could delay disease progression
Laurie J. Brown, Jinjing Li, Matthias Brunner, Martin Snoke & Hai A. La
Pages: 140-149
Published online: 29 Jan 2021
AbstractforSocietal costs of primary progressive multiple sclerosis in Australia and the economic impact of a hypothetical disease-modifying treatment that could delay disease progression | Full Text | References | PDF (1.2 MB) | EPUB | Supplemental
  • 2784 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access
Article
The cost-effectiveness of glasdegib in combination with low-dose cytarabine, for the treatment of newly diagnosed acute myeloid leukemia in adult patients who are not eligible to receive intensive induction chemotherapy in Canada
Yannan Hu, Majed Charaan, Ilse van Oostrum, Bart Heeg & Timothy Bell
Pages: 150-161
Published online: 01 Feb 2021
AbstractforThe cost-effectiveness of glasdegib in combination with low-dose cytarabine, for the treatment of newly diagnosed acute myeloid leukemia in adult patients who are not eligible to receive intensive induction chemotherapy in Canada | Full Text | References | PDF (2.1 MB) | EPUB | Supplemental
  • 2826 Views
  • 3 CrossRef citations
  • 0Altmetric
Open Access
Article
Willingness to pay for primary health care at public facilities in the Western Cape Province, Cape Town, South Africa
P. Chiwire, S. M. Evers, H. Mahomed & M. Hiligsmann
Pages: 162-172
Published online: 09 Feb 2021
AbstractforWillingness to pay for primary health care at public facilities in the Western Cape Province, Cape Town, South Africa | Full Text | References | PDF (1.3 MB) | EPUB
  • 3133 Views
  • 4 CrossRef citations
  • 0Altmetric
Open Access
Article
Comparison of cost-effectiveness of implantable cardioverter defibrillator therapy in patients for primary prevention in Latin America: an analysis using the Improve SCA study
Lucas Higuera, Reece Holbrook, Kael Wherry, Diego A. Rodriguez, Alejandro Cuesta, Juan Valencia, Julián Arcos & Agustín López Gómez
Pages: 173-180
Published online: 04 Feb 2021
AbstractforComparison of cost-effectiveness of implantable cardioverter defibrillator therapy in patients for primary prevention in Latin America: an analysis using the Improve SCA study | Full Text | References | PDF (1.3 MB) | EPUB
  • 2057 Views
  • 1 CrossRef citations
  • 0Altmetric
Open Access
Article
Humanistic burden among caregivers of patients with Alzheimer’s disease or dementia in Japan: a large-scale cross-sectional survey
Shinya Ohno, Yirong Chen, Hiroyuki Sakamaki, Naoki Matsumaru, Motoaki Yoshino & Katsura Tsukamoto
Pages: 181-192
Published online: 11 Feb 2021
AbstractforHumanistic burden among caregivers of patients with Alzheimer’s disease or dementia in Japan: a large-scale cross-sectional survey | Full Text | References | PDF (1.9 MB) | EPUB | Supplemental
  • 3558 Views
  • 9 CrossRef citations
  • 0Altmetric
Open Access
Article
Excess healthcare costs in patients with autosomal dominant polycystic kidney disease by renal dysfunction stage
Patrick Gagnon-Sanschagrin, Yawen Liang, Myrlene Sanon, Dorothee Oberdhan, Annie Guérin & Martin Cloutier
Pages: 193-201
Published online: 10 Feb 2021
AbstractforExcess healthcare costs in patients with autosomal dominant polycystic kidney disease by renal dysfunction stage | Full Text | References | PDF (1.8 MB) | EPUB | Supplemental
  • 1755 Views
  • 1 CrossRef citations
  • 0Altmetric
Open Access
Article
Hospitalizations and healthcare costs associated with rifaximin versus lactulose treatment among commercially insured patients with hepatic encephalopathy in the United States
Michael L. Volk, Rebecca Burne, Annie Guérin, Sherry Shi, George J. Joseph, Zeev Heimanson & Maliha Ahmad
Pages: 202-211
Published online: 24 Feb 2021
AbstractforHospitalizations and healthcare costs associated with rifaximin versus lactulose treatment among commercially insured patients with hepatic encephalopathy in the United States | Full Text | References | PDF (1 MB) | EPUB | Supplemental
  • 3267 Views
  • 11 CrossRef citations
  • 0Altmetric
Open Access
Article
Healthcare costs before and after stroke in patients with non-valvular atrial fibrillation who initiated treatment with rivaroxaban or warfarin
Dejan Milentijevic, Jennifer H. Lin, Yen-Wen Chen, Emily Kogan, Shubham Shrivastava, Erik Sjoeland & Mark Alberts
Pages: 212-217
Published online: 13 Feb 2021
AbstractforHealthcare costs before and after stroke in patients with non-valvular atrial fibrillation who initiated treatment with rivaroxaban or warfarin | Full Text | References | PDF (1.1 MB) | EPUB | Supplemental
  • 1729 Views
  • 2 CrossRef citations
  • 0Altmetric
Open Access
Article
Budget impact analysis of Jivi (damoctocog alfa pegol, Bay 94-9027) in severe hemophilia A in Japan
Teruhisa Fujii, Yuko Kidoguchi, Noriko Takahashi, Eric Yu, Dilinuer Ainiwaer & Aidan Byrne
Pages: 218-225
Published online: 14 Feb 2021
AbstractforBudget impact analysis of Jivi (damoctocog alfa pegol, Bay 94-9027) in severe hemophilia A in Japan | Full Text | References | PDF (897.9 KB) | EPUB | Supplemental
  • 2863 Views
  • 1 CrossRef citations
  • 0Altmetric
Open Access
Article
Estimating the preferences and willingness-to-pay for colorectal cancer screening: an opportunity to incorporate the perspective of population at risk into policy development in Thailand
Pochamana Phisalprapa, Surachat Ngorsuraches, Tanatape Wanishayakorn, Chayanis Kositamongkol, Siripen Supakankunti & Nathorn Chaiyakunapruk
Pages: 226-233
Published online: 12 Feb 2021
AbstractforEstimating the preferences and willingness-to-pay for colorectal cancer screening: an opportunity to incorporate the perspective of population at risk into policy development in Thailand | Full Text | References | PDF (1.1 MB) | EPUB | Supplemental
  • 2568 Views
  • 6 CrossRef citations
  • 0Altmetric
Open Access
Article
Healthcare resource utilization and costs in patients with myelodysplastic syndromes treated with hypomethylating agents: a SEER-Medicare analysis
Eytan M. Stein, Gaetano Bonifacio, Dominick Latrémouille-Viau, Sherry Shi, Annie Guérin, Eric Q. Wu, Islam Sadek & Xiting Cao
Pages: 234-243
Published online: 16 Feb 2021
AbstractforHealthcare resource utilization and costs in patients with myelodysplastic syndromes treated with hypomethylating agents: a SEER-Medicare analysis | Full Text | References | PDF (2.4 MB) | EPUB
  • 2729 Views
  • 5 CrossRef citations
  • 0Altmetric
Open Access
Article
Estimation of the value of convenience in taking influenza antivirals in Japanese adult patients between baloxavir marboxil and neuraminidase inhibitors using a conjoint analysis
Naoki Hosogaya, Takahiro Takazono, Akira Yokomasu, Shinzo Hiroi, Hidetoshi Ikeoka, Kosuke Iwasaki, Tomomi Takeshima & Hiroshi Mukae
Pages: 244-254
Published online: 12 Feb 2021
AbstractforEstimation of the value of convenience in taking influenza antivirals in Japanese adult patients between baloxavir marboxil and neuraminidase inhibitors using a conjoint analysis | Full Text | References | PDF (1.9 MB) | EPUB | Supplemental
  • 2762 Views
  • 7 CrossRef citations
  • 0Altmetric
Open Access
Article
Incidence, predictors, and economic burden of circular anastomotic complications in left-sided colorectal reconstructions involving manual circular staplers
Stephen P. Fortin, Stephen S. Johnston, Rusha Chaudhuri, Raymond Fryrear II & Sanjoy Roy
Pages: 255-265
Published online: 17 Feb 2021
AbstractforIncidence, predictors, and economic burden of circular anastomotic complications in left-sided colorectal reconstructions involving manual circular staplers | Full Text | References | PDF (1,009.7 KB) | EPUB | Supplemental
  • 1982 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access
Article
Burden of caring for Alzheimer’s disease or dementia patients in Japan, the US, and EU: results from the National Health and Wellness Survey: a cross-sectional survey
Shinya Ohno, Yirong Chen, Hiroyuki Sakamaki, Naoki Matsumaru, Motoaki Yoshino & Katsura Tsukamoto
Pages: 266-278
Published online: 19 Feb 2021
AbstractforBurden of caring for Alzheimer’s disease or dementia patients in Japan, the US, and EU: results from the National Health and Wellness Survey: a cross-sectional survey | Full Text | References | PDF (1.9 MB) | EPUB | Supplemental
  • 3923 Views
  • 10 CrossRef citations
  • 0Altmetric
Open Access
Article
Cost-effectiveness of tofacitinib compared with infliximab, adalimumab, golimumab, vedolizumab and ustekinumab for the treatment of moderate to severe ulcerative colitis in Germany
Aditya Sardesai, Axel Dignass, Peter Quon, Sandra Milev, Joseph C. Cappelleri, Agnes Kisser, Irene Modesto & Puza P. Sharma
Pages: 279-290
Published online: 24 Feb 2021
AbstractforCost-effectiveness of tofacitinib compared with infliximab, adalimumab, golimumab, vedolizumab and ustekinumab for the treatment of moderate to severe ulcerative colitis in Germany | Full Text | References | PDF (1.5 MB) | EPUB | Supplemental
  • 5755 Views
  • 5 CrossRef citations
  • 0Altmetric
Open Access
Article
Pembrolizumab plus axitinib and nivolumab plus ipilimumab as first-line treatments of advanced intermediate- or poor-risk renal-cell carcinoma: a number needed to treat analysis from the Brazilian private perspective
Tobias Engel Ayer Botrel, Márcia Datz Abadi, Laura Chabrol Haas, Cássia Rita Pereira da Veiga, Dominihemberg de Vasconcelos Ferreira & Denis Leonardo Jardim
Pages: 291-298
Published online: 01 Mar 2021
AbstractforPembrolizumab plus axitinib and nivolumab plus ipilimumab as first-line treatments of advanced intermediate- or poor-risk renal-cell carcinoma: a number needed to treat analysis from the Brazilian private perspective | Full Text | References | PDF (1 MB) | EPUB | Supplemental
  • 3799 Views
  • 4 CrossRef citations
  • 0Altmetric
Open Access
Article
Risk and cost of infection-related hospitalizations in medicare beneficiaries with comorbid rheumatoid arthritis treated with abatacept versus other targeted disease-modifying anti-rheumatic drugs
Vardhaman Patel, Zulkarnain Pulungan, Anne Shah, Mahesh Kambhampati, Francis Lobo & Allison Petrilla
Pages: 299-307
Published online: 23 Feb 2021
AbstractforRisk and cost of infection-related hospitalizations in medicare beneficiaries with comorbid rheumatoid arthritis treated with abatacept versus other targeted disease-modifying anti-rheumatic drugs | Full Text | References | PDF (1.1 MB) | EPUB | Supplemental
  • 1791 Views
  • 2 CrossRef citations
  • 0Altmetric
Open Access
Article
Health outcomes and economic burden of hospitalized COVID-19 patients in the United States
Manuela Di Fusco, Kimberly M. Shea, Jay Lin, Jennifer L. Nguyen, Frederick J. Angulo, Michael Benigno, Deepa Malhotra, Birol Emir, Anita H. Sung, Jennifer L. Hammond, Sophia Stoychev & Apostolos Charos
Pages: 308-317
Published online: 24 Feb 2021
AbstractforHealth outcomes and economic burden of hospitalized COVID-19 patients in the United States | Full Text | References | PDF (958.3 KB) | EPUB | Supplemental
  • 16640 Views
  • 87 CrossRef citations
  • 0Altmetric
Open Access
Brief Report
Modeling the economic value of Ceribell Rapid Response EEG in the inpatient hospital setting
John P. Ney, Kapil Gururangan & Josef Parvizi
Pages: 318-327
Published online: 23 Feb 2021
AbstractforModeling the economic value of Ceribell Rapid Response EEG in the inpatient hospital setting | Full Text | References | PDF (1.7 MB) | EPUB
  • 5386 Views
  • 9 CrossRef citations
  • 0Altmetric
Open Access
Article
Real-world impact of brain metastases on healthcare utilization and costs in patients with non-small cell lung cancer treated with EGFR-TKIs in the US
Amanda M. Kong, Melissa Pavilack, Hairong Huo, Rahul Shenolikar, Meghan Moynihan, Elizabeth H. Marchlewicz, Christina Chebili-Larson, Stella Min & Deepa S. Subramaniam
Pages: 328-338
Published online: 01 Mar 2021
AbstractforReal-world impact of brain metastases on healthcare utilization and costs in patients with non-small cell lung cancer treated with EGFR-TKIs in the US | Full Text | References | PDF (1.3 MB) | EPUB | Supplemental
  • 2272 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access
Article
Cost-effectiveness analysis of fruquintinib versus regorafenib as the third-line therapy for metastatic colorectal cancer in China
Xin Guan, Hongchao Li, Xiaomo Xiong, Cike Peng, Ning Wang, Xiao Ma & Aixia Ma
Pages: 339-344
Published online: 01 Mar 2021
AbstractforCost-effectiveness analysis of fruquintinib versus regorafenib as the third-line therapy for metastatic colorectal cancer in China | Full Text | References | PDF (868.3 KB) | EPUB | Supplemental
  • 4035 Views
  • 7 CrossRef citations
  • 0Altmetric
Open Access
Article
Influence of neurovascular embolic coil primary wind diameter on aneurysm packing density and case costs
Ramesh Grandhi, Emilie Kottenmeier, Heather L. Cameron, Sarah T. Kane & Philipp Taussky
Pages: 345-351
Published online: 08 Mar 2021
AbstractforInfluence of neurovascular embolic coil primary wind diameter on aneurysm packing density and case costs | Full Text | References | PDF (1.1 MB) | EPUB
  • 1891 Views
  • 2 CrossRef citations
  • 0Altmetric
Open Access
Article
Healthcare resource utilization, costs and treatment patterns in patients with bipolar disorder treated with lurasidone or cariprazine
Huan Huang, Luke Schmerold, Carole Dembek, Qi Fan, Christopher Dieyi, G. Rhys Williams & Antony Loebel
Pages: 352-362
Published online: 02 Mar 2021
AbstractforHealthcare resource utilization, costs and treatment patterns in patients with bipolar disorder treated with lurasidone or cariprazine | Full Text | References | PDF (1.3 MB) | EPUB | Supplemental
  • 3201 Views
  • 1 CrossRef citations
  • 0Altmetric
Open Access
Article
Adult lifetime cost of hemophilia B management in the US: payer and societal perspectives from a decision analytic model
Nanxin Li, Eileen K. Sawyer, Konrad Maruszczyk, Greg Guzauskas, Marta T. Slomka, Tom Burke, Antony P. Martin, Jamie O’Hara, Matt Stevenson & Michael Recht
Pages: 363-372
Published online: 02 Mar 2021
AbstractforAdult lifetime cost of hemophilia B management in the US: payer and societal perspectives from a decision analytic model | Full Text | References | PDF (2.2 MB) | EPUB | Supplemental
  • 5286 Views
  • 8 CrossRef citations
  • 0Altmetric
Open Access
Article
A pragmatic methodology for the evaluation of digital care management in the context of multimorbidity
Emily Lindemer, Mohammad Jouni, Nikolay Nikolaev, Pat Reidy, Heather Mattie, Jameson K. Rogers, LouAnne Giangreco, Michael Sherman, Matthew Bartels & Trishan Panch
Pages: 373-385
Published online: 27 Mar 2021
AbstractforA pragmatic methodology for the evaluation of digital care management in the context of multimorbidity | Full Text | References | PDF (2 MB) | EPUB
  • 5419 Views
  • 2 CrossRef citations
  • 0Altmetric
Open Access
Article
Antiviral use is associated with a decrease in the rate of influenza-related complications, health care resource utilization, and costs
Chris Wallick, Ning Wu, Tu My To, Daniel Keebler & Dalia Moawad
Pages: 386-393
Published online: 10 Mar 2021
AbstractforAntiviral use is associated with a decrease in the rate of influenza-related complications, health care resource utilization, and costs | Full Text | References | PDF (775.7 KB) | EPUB | Supplemental
  • 1614 Views
  • 3 CrossRef citations
  • 0Altmetric
Open Access
Article
Standard table direct anterior approach within an early discharge protocol for cementless total hip arthroplasty: experience from a Japanese hospital
Yoshiatsu Nakakita, Anh Bourcet, Jack Mantel, HyeJin Park, Anne Rossi, Kazuhiro Oinuma & Hideaki Shiratsuchi
Pages: 394-401
Published online: 10 Mar 2021
AbstractforStandard table direct anterior approach within an early discharge protocol for cementless total hip arthroplasty: experience from a Japanese hospital | Full Text | References | PDF (864.9 KB) | EPUB
  • 1939 Views
  • 1 CrossRef citations
  • 0Altmetric
Open Access
Article
Healthcare resource utilization and costs of major atherothrombotic vascular events among patients with peripheral artery disease after revascularization
Urvi Desai, Akshay Kharat, Connie N. Hess, Dejan Milentijevic, François Laliberté, Peter Zuckerman, John Benson, Patrick Lefebvre, William R. Hiatt & Marc P. Bonaca
Pages: 402-409
Published online: 12 Mar 2021
AbstractforHealthcare resource utilization and costs of major atherothrombotic vascular events among patients with peripheral artery disease after revascularization | Full Text | References | PDF (1.3 MB) | EPUB
  • 1909 Views
  • 4 CrossRef citations
  • 0Altmetric
Open Access
Article
Corneal cross-linking versus conventional management for keratoconus: a lifetime economic model
Richard L. Lindstrom, John P. Berdahl, Eric D. Donnenfeld, Vance Thompson, David Kratochvil, Chiang Wong, Heather Falvey, Grace Lytle, Marc F. Botteman & John A. Carter
Pages: 410-420
Published online: 18 Mar 2021
AbstractforCorneal cross-linking versus conventional management for keratoconus: a lifetime economic model | Full Text | References | PDF (2.5 MB) | EPUB
  • 3403 Views
  • 9 CrossRef citations
  • 0Altmetric
Open Access
Article
Cost-effectiveness for KTE-X19 CAR T therapy for adult patients with relapsed/refractory mantle cell lymphoma in the United States
Claire L. Simons, Daniel Malone, Michael Wang, Gregory A. Maglinte, Tim Inocencio, Sally W. Wade, Craig Bennison & Bijal Shah
Pages: 421-431
Published online: 24 Mar 2021
AbstractforCost-effectiveness for KTE-X19 CAR T therapy for adult patients with relapsed/refractory mantle cell lymphoma in the United States | Full Text | References | PDF (2.5 MB) | EPUB | Supplemental
  • 6525 Views
  • 12 CrossRef citations
  • 0Altmetric
Open Access
Article
Burden of acromegaly in the United States: increased health services utilization, location of care, and costs of care
Antonio Ribeiro-Oliveira Jr, Richard A. Brook, Kathryn A. Munoz, Ian A. Beren, John D. Whalen, Nathan L. Kleinman & Kevin C. J. Yuen
Pages: 432-439
Published online: 31 Mar 2021
AbstractforBurden of acromegaly in the United States: increased health services utilization, location of care, and costs of care | Full Text | References | PDF (1.2 MB) | EPUB
  • 1960 Views
  • 4 CrossRef citations
  • 0Altmetric
Open Access
Article
The direct and indirect economic burden of hypothyroidism in the United States: a retrospective claims database study
Zsolt Hepp, Maureen J. Lage, Ramon Espaillat & Ved V. Gossain
Pages: 440-446
Published online: 30 Mar 2021
AbstractforThe direct and indirect economic burden of hypothyroidism in the United States: a retrospective claims database study | Full Text | References | PDF (762.7 KB) | EPUB
  • 5751 Views
  • 6 CrossRef citations
  • 0Altmetric
Open Access
Article
The cost-effectiveness of dacomitinib in first-line treatment of advanced/metastatic epidermal growth factor receptor mutation-positive non-small-cell lung cancer (EGFRm NSCLC) in Sweden
Fredrik O. L. Nilsson, Peter Gal, Ivan Houisse, Jasmina I. Ivanova & Sandra T. Asanin
Pages: 447-457
Published online: 09 Apr 2021
AbstractforThe cost-effectiveness of dacomitinib in first-line treatment of advanced/metastatic epidermal growth factor receptor mutation-positive non-small-cell lung cancer (EGFRm NSCLC) in Sweden | Full Text | References | PDF (1.2 MB) | EPUB | Supplemental
  • 2851 Views
  • 2 CrossRef citations
  • 0Altmetric
Open Access
Article
Cost effectiveness of axicabtagene ciloleucel versus tisagenlecleucel for adult patients with relapsed or refractory large B-cell lymphoma after two or more lines of systemic therapy in the United States
Rongzhe Liu, Olalekan O. Oluwole, Ibrahim Diakite, Marc F. Botteman, Julia Thornton Snider & Frederick L. Locke
Pages: 458-468
Published online: 26 May 2021
AbstractforCost effectiveness of axicabtagene ciloleucel versus tisagenlecleucel for adult patients with relapsed or refractory large B-cell lymphoma after two or more lines of systemic therapy in the United States | Full Text | References | PDF (1.8 MB) | EPUB | Supplemental
  • 6982 Views
  • 16 CrossRef citations
  • 0Altmetric
Open Access
Article
Treatment patterns, healthcare resource utilization, and costs of patients diagnosed with primary mediastinal B-cell lymphoma in the United States
Xiaoqin Yang, François Laliberté, Guillaume Germain, Monika Raut, Mei Sheng Duh, Shuvayu S. Sen, Dominique Lejeune, Kaushal Desai & Philippe Armand
Pages: 469-478
Published online: 13 Apr 2021
AbstractforTreatment patterns, healthcare resource utilization, and costs of patients diagnosed with primary mediastinal B-cell lymphoma in the United States | Full Text | References | PDF (1.3 MB) | EPUB | Supplemental
  • 2043 Views
  • 1 CrossRef citations
  • 0Altmetric
Open Access
Article
The implications of suboptimal year-1 outcomes with disease-modifying therapy in employees with multiple sclerosis
Carrie M. Hersh, Richard A. Brook, Ian A. Beren, Nicholas J. Rohrbacker, Lori Lebson, Christian Henke & Amy L. Phillips
Pages: 479-486
Published online: 13 Apr 2021
AbstractforThe implications of suboptimal year-1 outcomes with disease-modifying therapy in employees with multiple sclerosis | Full Text | References | PDF (1.2 MB) | EPUB | Supplemental
  • 1795 Views
  • 3 CrossRef citations
  • 0Altmetric
Open Access
Editorial
Budget impact analysis: can we afford the added value?
Panagiotis Petrou
Pages: 487-489
Published online: 15 Apr 2021
First Page PreviewforBudget impact analysis: can we afford the added value? | Full Text | References | PDF (298.9 KB) | EPUB
  • 2822 Views
  • 4 CrossRef citations
  • 0Altmetric
Open Access
Article
Cost-effectiveness of the cell-based quadrivalent versus the standard egg-based quadrivalent influenza vaccine in Germany
Rui Cai, Laetitia Gerlier, Martin Eichner, Markus Schwehm, Sankarasubramanian Rajaram, Joaquin Mould-Quevedo & Mark Lamotte
Pages: 490-501
Published online: 19 Apr 2021
AbstractforCost-effectiveness of the cell-based quadrivalent versus the standard egg-based quadrivalent influenza vaccine in Germany | Full Text | References | PDF (2.2 MB) | EPUB | Supplemental
  • 3730 Views
  • 6 CrossRef citations
  • 0Altmetric
Open Access
Review Article
Setting and maintaining standards for patient-reported outcome measures: can we rely on the COSMIN checklists?
Stephen P. McKenna & Alice Heaney
Pages: 502-511
Published online: 26 Apr 2021
AbstractforSetting and maintaining standards for patient-reported outcome measures: can we rely on the COSMIN checklists? | Full Text | References | PDF (1 MB) | EPUB
  • 3702 Views
  • 10 CrossRef citations
  • 0Altmetric
Open Access
Letter
Novel acute therapies in the treatment of migraine: impact of re-dosing on cost–utility outcomes
Karissa M. Johnston, Gilbert L'italien, Linda Harris, Alison Deighton, Evan Popoff, Robert Croop & Vladimir Coric
Pages: 512-513
Published online: 23 Apr 2021
CitationforNovel acute therapies in the treatment of migraine: impact of re-dosing on cost–utility outcomes | Full Text | References | PDF (237.7 KB) | EPUB
  • 2076 Views
  • 1 CrossRef citations
  • 0Altmetric
Open Access
Article
Impact of an active hemostatic product treatment approach on bleeding-related complications and hospital costs among inpatient surgeries in the United States
David A. Iannitti, Chong Kim, Diane Ito & Josh Epstein
Pages: 514-523
Published online: 29 Apr 2021
AbstractforImpact of an active hemostatic product treatment approach on bleeding-related complications and hospital costs among inpatient surgeries in the United States | Full Text | References | PDF (1.9 MB) | EPUB | Supplemental
  • 4097 Views
  • 5 CrossRef citations
  • 0Altmetric
Open Access
Article
A device category economic model of electrosurgery technologies across procedure types: a U.S. hospital budget impact analysis
Nicole Ferko, George W. J. Wright, Imran Syed, Elena Naoumtchik, Giovanni A. Tommaselli & Gaurav Gangoli
Pages: 524-535
Published online: 28 Apr 2021
AbstractforA device category economic model of electrosurgery technologies across procedure types: a U.S. hospital budget impact analysis | Full Text | References | PDF (2 MB) | EPUB | Supplemental
  • 3319 Views
  • 2 CrossRef citations
  • 0Altmetric
Open Access
Article Commentary
Is there a correlation between total fertility rate, utilization of assisted reproduction technology, and national wealth in Europe?
Amir Lass & Geffen Lass
Pages: 536-539
Published online: 28 Apr 2021
AbstractforIs there a correlation between total fertility rate, utilization of assisted reproduction technology, and national wealth in Europe? | Full Text | References | PDF (574.7 KB) | EPUB
  • 1591 Views
  • 2 CrossRef citations
  • 0Altmetric
Open Access
Article
Real-world assessment of “OFF” episode–related healthcare resource utilization among patients with Parkinson’s disease in the United States
Andrew Thach, Eddie Jones, Eric Pappert, James Pike, Jack Wright & Alexander Gillespie
Pages: 540-549
Published online: 04 May 2021
AbstractforReal-world assessment of “OFF” episode–related healthcare resource utilization among patients with Parkinson’s disease in the United States | Full Text | References | PDF (915.7 KB) | EPUB | Supplemental
  • 2399 Views
  • 3 CrossRef citations
  • 0Altmetric
Open Access
Article
Healthcare resource utilization and costs of rivaroxaban versus warfarin among non-valvular atrial fibrillation (NVAF) patients with obesity in a US population
Jeffrey S. Berger, François Laliberté, Akshay Kharat, Dominique Lejeune, Kenneth Todd Moore, Young Jung, Patrick Lefebvre & Veronica Ashton
Pages: 550-562
Published online: 08 May 2021
AbstractforHealthcare resource utilization and costs of rivaroxaban versus warfarin among non-valvular atrial fibrillation (NVAF) patients with obesity in a US population | Full Text | References | PDF (1.6 MB) | EPUB | Supplemental
  • 1911 Views
  • 4 CrossRef citations
  • 0Altmetric
Open Access
Article
Cost-effectiveness of opicapone and entacapone in reducing OFF-time in Parkinson’s disease patients treated with levodopa/carbidopa
Ryan N. Hansen, Kangho Suh, Michael Serbin, Chuck Yonan & Sean D. Sullivan
Pages: 563-569
Published online: 04 May 2021
AbstractforCost-effectiveness of opicapone and entacapone in reducing OFF-time in Parkinson’s disease patients treated with levodopa/carbidopa | Full Text | References | PDF (1.5 MB) | EPUB
  • 3353 Views
  • 3 CrossRef citations
  • 0Altmetric
Open Access
Article
Two-year PAD-related health care costs in patients undergoing lower extremity endovascular revascularization: results from the LIBERTY 360° trial
Elizabeth A. Magnuson, Haiyan Li, Katherine Vilain, Ehrin J. Armstrong, Eric A. Secemsky, Stefanos Giannopoulos, George L. Adams, Jihad Mustapha, David J. Cohen, on behalf of the LIBERTY 360° Trial Investigators & on behalf of the LIBERTY 360° Trial Investigators
Pages: 570-580
Published online: 07 May 2021
AbstractforTwo-year PAD-related health care costs in patients undergoing lower extremity endovascular revascularization: results from the LIBERTY 360° trial | Full Text | References | PDF (2.7 MB) | EPUB | Supplemental
  • 2766 Views
  • 1 CrossRef citations
  • 0Altmetric
Open Access
Article
Identification and temporal trends of patients with neuromyelitis optica spectrum disorder in a US insurance claims database
Alex Exuzides, Ning Wu, Daniel Sheinson, Carlos Flores Avile, Cristina Costantino & Paris Sidiropoulos
Pages: 581-588
Published online: 05 May 2021
AbstractforIdentification and temporal trends of patients with neuromyelitis optica spectrum disorder in a US insurance claims database | Full Text | References | PDF (1.7 MB) | EPUB | Supplemental
  • 2104 Views
  • 1 CrossRef citations
  • 0Altmetric
Open Access
Article
Real-world data analysis of the clinical and economic burden and risk factors in patients with major depressive disorder with an inadequate response to initial antidepressants
HyeJin Park, Chan Mi Park, Jong-Min Woo, Ju-Young Shin, Eui-Kyung Lee & Sun-Hong Kwon
Pages: 589-597
Published online: 06 May 2021
AbstractforReal-world data analysis of the clinical and economic burden and risk factors in patients with major depressive disorder with an inadequate response to initial antidepressants | Full Text | References | PDF (1.5 MB) | EPUB | Supplemental
  • 2109 Views
  • 3 CrossRef citations
  • 0Altmetric
Open Access
Article
Conversion from pegfilgrastim with on-body injector to pegfilgrastim-jmdb: cost-efficiency analysis and budget-neutral expanded access to prophylaxis and treatment
Ali McBride, Karen MacDonald, Adolfo Fuentes-Alburo & Ivo Abraham
Pages: 598-606
Published online: 10 May 2021
AbstractforConversion from pegfilgrastim with on-body injector to pegfilgrastim-jmdb: cost-efficiency analysis and budget-neutral expanded access to prophylaxis and treatment | Full Text | References | PDF (1.1 MB) | EPUB
  • 3000 Views
  • 5 CrossRef citations
  • 0Altmetric
Open Access
Article
Cost-effectiveness of nivolumab in squamous and non-squamous non-small cell lung cancer in Canada and Sweden: an update with 5-year data
Mohammad A. Chaudhary, Christoffer Holmberg, Khalid Lakhdari, Caitlin Smare, Chloi Theriou, Peter Dale & John R. Penrod
Pages: 607-619
Published online: 06 May 2021
AbstractforCost-effectiveness of nivolumab in squamous and non-squamous non-small cell lung cancer in Canada and Sweden: an update with 5-year data | Full Text | References | PDF (2.4 MB) | EPUB | Supplemental
  • 3447 Views
  • 4 CrossRef citations
  • 0Altmetric
Open Access
Article
Cost burden of post-transplant lymphoproliferative disease following kidney transplants in Medicare-eligible patients by survival status
Allyson Hart, Yoon Son Ahn, Crystal Watson, Melissa Skeans, Arie Barlev, Bryn Thompson & Vikas R. Dharnidharka
Pages: 620-627
Published online: 17 May 2021
AbstractforCost burden of post-transplant lymphoproliferative disease following kidney transplants in Medicare-eligible patients by survival status | Full Text | References | PDF (1.1 MB) | EPUB | Supplemental
  • 1753 Views
  • 1 CrossRef citations
  • 0Altmetric
Open Access
Article
Cost-effectiveness analysis of defibrotide in the treatment of patients with severe veno-occlusive disease/sinusoidal obstructive syndrome with multiorgan dysfunction following hematopoietic cell transplantation in Spain
David Carcedo Rodriguez, Teresa Artola Urain, Anabelle Chinea Rodriguez, Estefanía García Torres, Marta González Vicent, Gonzalo Gutiérrez García, Alexandra Regueiro García, Marcos Calvo Hidalgo & Alba Villacampa
Pages: 628-636
Published online: 13 May 2021
AbstractforCost-effectiveness analysis of defibrotide in the treatment of patients with severe veno-occlusive disease/sinusoidal obstructive syndrome with multiorgan dysfunction following hematopoietic cell transplantation in Spain | Full Text | References | PDF (1.5 MB) | EPUB | Supplemental
  • 2000 Views
  • 3 CrossRef citations
  • 0Altmetric
Open Access
Article
Cost-effectiveness and budget impact analyses of tisagenlecleucel in adult patients with relapsed or refractory diffuse large B-cell lymphoma from Singapore’s private insurance payer’s perspective
Xiao Jun Wang, Yi-Ho Wang, Shing Chau Tony Li, Christina Gkitzia, Soon Thye Lim, Liang Piu Koh, Francesca Lorraine Wei Inng Lim & William Ying Khee Hwang
Pages: 637-653
Published online: 12 May 2021
AbstractforCost-effectiveness and budget impact analyses of tisagenlecleucel in adult patients with relapsed or refractory diffuse large B-cell lymphoma from Singapore’s private insurance payer’s perspective | Full Text | References | PDF (1.7 MB) | EPUB
  • 5480 Views
  • 6 CrossRef citations
  • 0Altmetric
Open Access
Article
Real-world cost-effectiveness of stool-based colorectal cancer screening in a Medicare population
Deborah A. Fisher, Jordan J. Karlitz, Sushanth Jeyakumar, Nathaniel Smith, Paul Limburg, David Lieberman & A. Mark Fendrick
Pages: 654-664
Published online: 12 May 2021
AbstractforReal-world cost-effectiveness of stool-based colorectal cancer screening in a Medicare population | Full Text | References | PDF (1.5 MB) | EPUB | Supplemental
  • 5153 Views
  • 4 CrossRef citations
  • 0Altmetric
Open Access
Article
Biosimilar pegfilgrastim may offer affordable treatment options for patients in France: a budget impact analysis on the basis of clinical trial and real-world data
Jingyan Yang, Rongzhe Liu, Anna Granghaud, Omer Zaidi & Jennifer Stephens
Pages: 665-674
Published online: 12 May 2021
AbstractforBiosimilar pegfilgrastim may offer affordable treatment options for patients in France: a budget impact analysis on the basis of clinical trial and real-world data | Full Text | References | PDF (1.3 MB) | EPUB
  • 1898 Views
  • 3 CrossRef citations
  • 0Altmetric
Open Access
Article
Cost-effectiveness of pembrolizumab compared with chemotherapy in the US for women with previously treated deficient mismatch repair or high microsatellite instability unresectable or metastatic endometrial cancer
Elizabeth Thurgar, Mark Gouldson, Suzette Matthijsse, Mayur Amonkar, Patricia Marinello, Navneet Upadhyay, Chizoba Nwankwo & Raquel Aguiar-Ibáñez
Pages: 675-688
Published online: 13 May 2021
AbstractforCost-effectiveness of pembrolizumab compared with chemotherapy in the US for women with previously treated deficient mismatch repair or high microsatellite instability unresectable or metastatic endometrial cancer | Full Text | References | PDF (1.9 MB) | EPUB | Supplemental
  • 4286 Views
  • 11 CrossRef citations
  • 0Altmetric
Open Access
Article Commentary
Continuity and change in the drug supply chain: actors, actions, and aversions
Roger Lee Mendoza
Pages: 689-697
Published online: 26 May 2021
AbstractforContinuity and change in the drug supply chain: actors, actions, and aversions | Full Text | References | PDF (864.5 KB) | EPUB
  • 3541 Views
  • 4 CrossRef citations
  • 0Altmetric
Open Access
Article
Quality outcomes, healthcare resource utilization and costs in Medicare patients with chronic heart failure with reduced ejection fraction with and without a worsening event
Robert J. Mentz, Zulkarnain Pulungan, Seung Kim, Mei Yang, Christie Teigland, Robert Hilkert & Laurence M. Djatche
Pages: 698-705
Published online: 28 May 2021
AbstractforQuality outcomes, healthcare resource utilization and costs in Medicare patients with chronic heart failure with reduced ejection fraction with and without a worsening event | Full Text | References | PDF (1.5 MB) | EPUB | Supplemental
  • 2204 Views
  • 4 CrossRef citations
  • 0Altmetric
Open Access
Article
Burden of illness among Medicare and non-Medicare US populations with acquired thrombotic thrombocytopenic purpura
Laurence Pollissard, Anne Shah, Rajeshwari S. Punekar, Allison Petrilla & Huy P. Pham
Pages: 706-716
Published online: 26 May 2021
AbstractforBurden of illness among Medicare and non-Medicare US populations with acquired thrombotic thrombocytopenic purpura | Full Text | References | PDF (1.1 MB) | EPUB | Supplemental
  • 2517 Views
  • 2 CrossRef citations
  • 0Altmetric
Open Access
Article
Healthcare resource use and indirect costs associated with migraine in Italy: results from the My Migraine Voice survey
Paolo Martelletti, Todd J. Schwedt, Pamela Vo, Daniela Ritrovato, Margaret C. Reilly, Mariantonietta Naclerio, Pallavi Ranjan, Joern Kleebach & Parth Joshi
Pages: 717-726
Published online: 01 Jun 2021
AbstractforHealthcare resource use and indirect costs associated with migraine in Italy: results from the My Migraine Voice survey | Full Text | References | PDF (1.4 MB) | EPUB
  • 2657 Views
  • 8 CrossRef citations
  • 0Altmetric
Open Access
Editorial
Cost-effectiveness of defibrotide for treatment of severe veno-occlusive disease: it is time for evidence based economic evaluations
Alois Gratwohl
Pages: 727-729
Published online: 31 May 2021
First Page PreviewforCost-effectiveness of defibrotide for treatment of severe veno-occlusive disease: it is time for evidence based economic evaluations | Full Text | References | PDF (300.1 KB) | EPUB
  • 1569 Views
  • 3 CrossRef citations
  • 0Altmetric
Open Access
Article
Economic evaluation of home medication review by community pharmacists (HMR-CP) for patients with type 2 diabetes mellitus (T2DM)
Mohd Rozaini Rosli, David Bin-Chia Wu, Chin Fen Neoh & Mahmathi Karuppannan
Pages: 730-740
Published online: 31 May 2021
AbstractforEconomic evaluation of home medication review by community pharmacists (HMR-CP) for patients with type 2 diabetes mellitus (T2DM) | Full Text | References | PDF (1.6 MB) | EPUB | Supplemental
  • 2278 Views
  • 1 CrossRef citations
  • 0Altmetric
Open Access
Editorial
The tyranny of the SW quadrant
Panagiotis Petrou
Pages: 741-742
Published online: 04 Jun 2021
CitationforThe tyranny of the SW quadrant | Full Text | References | PDF (235.6 KB) | EPUB
  • 1409 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access
Article
Cost-efficiency and expanded access modeling of conversion to biosimilar trastuzumab-dkst with or without pertuzumab in metastatic breast cancer
Ali McBride, Karen MacDonald, Adolfo Fuentes-Alburo & Ivo Abraham
Pages: 743-756
Published online: 11 Jun 2021
AbstractforCost-efficiency and expanded access modeling of conversion to biosimilar trastuzumab-dkst with or without pertuzumab in metastatic breast cancer | Full Text | References | PDF (1.5 MB) | EPUB | Supplemental
  • 2614 Views
  • 7 CrossRef citations
  • 0Altmetric
Open Access
Article
Criteria for oral appliance and/or supine avoidance therapy selection based on outcome optimization and cost-effectiveness
Daniel J. Levendowski, Richard Olmstead, Edward Sall, Philip R. Westbrook, Bretton Beine & Dominic Munafo
Pages: 757-763
Published online: 04 Jun 2021
AbstractforCriteria for oral appliance and/or supine avoidance therapy selection based on outcome optimization and cost-effectiveness | Full Text | References | PDF (759.7 KB) | EPUB
  • 1374 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access
Review Article
Modelling the value of innovative treatments for Alzheimer’s disease in the United States
Charles Makin, Peter Neumann, Sue Peschin & Dana Goldman
Pages: 764-769
Published online: 04 Jun 2021
AbstractforModelling the value of innovative treatments for Alzheimer’s disease in the United States | Full Text | References | PDF (726.2 KB) | EPUB
  • 2398 Views
  • 4 CrossRef citations
  • 0Altmetric
Open Access
Article
Modeling the cost-effectiveness of prolonged-release fampridine for the treatment of walking impairment in patients with multiple sclerosis in Sweden
Carlos Acosta, Mattia Gianinazzi, Thibaut Dort, Nigel Armstrong, Steve Ryder, Thomas Lundqvist, Mats Ekelund & Jan Lycke
Pages: 770-780
Published online: 21 Jun 2021
AbstractforModeling the cost-effectiveness of prolonged-release fampridine for the treatment of walking impairment in patients with multiple sclerosis in Sweden | Full Text | References | PDF (1.8 MB) | EPUB | Supplemental
  • 1985 Views
  • 1 CrossRef citations
  • 0Altmetric
Open Access
Correction
Correction
Page: 781
Published online: 14 Jun 2021
CitationforCorrection | Full Text | PDF (94.6 KB) | EPUB
  • 658 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access
Article
Dose escalation and associated costs in biologic treatment of psoriasis based on real-world data
Jerry Bagel, Brad Glick, Jashin J. Wu, Ishveen Chopra, Xue Song, Matthew Brouillette, Alan Mendelsohn, Stephen Rozzo & George Han
Pages: 782-791
Published online: 17 Jun 2021
AbstractforDose escalation and associated costs in biologic treatment of psoriasis based on real-world data | Full Text | References | PDF (1.5 MB) | EPUB
  • 2691 Views
  • 5 CrossRef citations
  • 0Altmetric
Open Access
Article
Cost-effectiveness of pembrolizumab + chemotherapy versus chemotherapy and pembrolizumab monotherapy in first line treatment of NSCLC in the US – updated analyses with additional trial follow-up
Ralph P. Insinga, Josephine L. Feliciano, Nan Qiao, Kristel Vandormael & Ying Zhang
Pages: 792-805
Published online: 25 Jun 2021
AbstractforCost-effectiveness of pembrolizumab + chemotherapy versus chemotherapy and pembrolizumab monotherapy in first line treatment of NSCLC in the US – updated analyses with additional trial follow-up | Full Text | References | PDF (2.1 MB) | EPUB | Supplemental
  • 3247 Views
  • 1 CrossRef citations
  • 0Altmetric
Open Access
Article
Comparison of healthcare resource utilization and costs of patients with HR+/HER2- advanced breast cancer treated with ribociclib versus other CDK4/6 inhibitors
Rebecca Burne, Sanjeev Balu, Annie Guérin, Rebecca Bungay, Roxana Sin & Mary Lisha Paul
Pages: 806-815
Published online: 25 Jun 2021
AbstractforComparison of healthcare resource utilization and costs of patients with HR+/HER2- advanced breast cancer treated with ribociclib versus other CDK4/6 inhibitors | Full Text | References | PDF (1.5 MB) | EPUB | Supplemental
  • 2827 Views
  • 4 CrossRef citations
  • 0Altmetric
Open Access
Article
Budget impact of tepotinib in the treatment of adult patients with metastatic non-small cell lung cancer harboring METex14 skipping alterations in the United States
Matthew Stargardter, Ali McBride, Jon Tosh, Rameet Sachdev, Mo Yang, Apoorva Ambavane, Madhav Mittal, Helene Vioix & Frank Xiaoqing Liu
Pages: 816-827
Published online: 05 Jul 2021
AbstractforBudget impact of tepotinib in the treatment of adult patients with metastatic non-small cell lung cancer harboring METex14 skipping alterations in the United States | Full Text | References | PDF (1.6 MB) | EPUB | Supplemental
  • 3450 Views
  • 3 CrossRef citations
  • 0Altmetric
Open Access
Article
The impact of seven major noncommunicable diseases on direct medical costs, absenteeism, and presenteeism in Gulf Cooperation Council countries
Eric Andrew Finkelstein, Jesse D. Malkin, Drishti Baid, Ada Alqunaibet, Khaled Mahdi, Mohammed Bin Hamad Al-Thani, Buthaina Abdulla Bin Belaila, Ebrahim Al Nawakhtha, Saleh Alqahtani, Sameh El-Saharty & Christopher H. Herbst
Pages: 828-834
Published online: 06 Jul 2021
AbstractforThe impact of seven major noncommunicable diseases on direct medical costs, absenteeism, and presenteeism in Gulf Cooperation Council countries | Full Text | References | PDF (832.5 KB) | EPUB
  • 5202 Views
  • 5 CrossRef citations
  • 0Altmetric
Open Access
Letter
Re: Ganz ML, Chavan A, Dhanda R, et al. Cost-effectiveness of valbenazine compared with deutetrabenazine for the treatment of tardive dyskinesia. J Med Econ. 2021;24(1):103–113
Weiguang Xue, Rinat Ribalov, Zheng-Yi Zhou, Rajeev Ayyagari & Sam Leo
Pages: 835-836
Published online: 19 Jul 2021
CitationforRe: Ganz ML, Chavan A, Dhanda R, et al. Cost-effectiveness of valbenazine compared with deutetrabenazine for the treatment of tardive dyskinesia. J Med Econ. 2021;24(1):103–113 | Full Text | References | PDF (345.3 KB) | EPUB
  • 1275 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access
Article
The improved survival rate and cost-effectiveness of a 7-day continuous subcutaneous insulin infusion set
Timothy Kwa, Gina Zhang, Katie Shepard, Kael Wherry & Sarnath Chattaraj
Pages: 837-845
Published online: 08 Jul 2021
AbstractforThe improved survival rate and cost-effectiveness of a 7-day continuous subcutaneous insulin infusion set | Full Text | References | PDF (1.7 MB) | EPUB | Supplemental
  • 2464 Views
  • 4 CrossRef citations
  • 0Altmetric
Open Access
Article
The most important facilitators and barriers to the use of Health Technology Assessment in Canada: a best–worst scaling approach
Wiesława Dominika Wranik, Ronaldo-Raul Székely, Susanne Mayer, Mickaël Hiligsmann & Kei Long Cheung
Pages: 846-856
Published online: 08 Jul 2021
AbstractforThe most important facilitators and barriers to the use of Health Technology Assessment in Canada: a best–worst scaling approach | Full Text | References | PDF (1.4 MB) | EPUB | Supplemental
  • 2219 Views
  • 1 CrossRef citations
  • 0Altmetric
Open Access
Letter
Reply to the concerns raised by McKenna and Heaney about COSMIN
Lidwine B. Mokkink, Caroline B. Terwee, Henrica C. W de Vet, Lex M. Bouter, Jordi Alonso & D. Patrick
Pages: 857-859
Published online: 12 Jul 2021
First Page PreviewforReply to the concerns raised by McKenna and Heaney about COSMIN | Full Text | References | PDF (303.2 KB) | EPUB
  • 2214 Views
  • 2 CrossRef citations
  • 0Altmetric
Open Access
COSMIN reviews: the need to consider measurement theory, modern measurement and a prospective rather than retrospective approach to evaluating patient-based measures
Stephen P. McKenna & Alice Heaney
Pages: 860-861
Published online: 12 Jul 2021
CitationforCOSMIN reviews: the need to consider measurement theory, modern measurement and a prospective rather than retrospective approach to evaluating patient-based measures | Full Text | References | PDF (453.8 KB) | EPUB
  • 1357 Views
  • 1 CrossRef citations
  • 0Altmetric
Open Access
Letter
Re: Harris L, Graham S, MacLachlan S, et al. Healthcare resource utilization by patients with treatment-refractory myasthenia gravis in England. J Med Econ. 2019;22(7):691–697
Victor Kiri & Gilbert MacKenzie
Pages: 862-863
Published online: 16 Jul 2021
CitationforRe: Harris L, Graham S, MacLachlan S, et al. Healthcare resource utilization by patients with treatment-refractory myasthenia gravis in England. J Med Econ. 2019;22(7):691–697 | Full Text | References | PDF (239.3 KB) | EPUB
  • 792 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access
Letter
Reply: Re: Harris L, Graham S, MacLachlan S, et al. Healthcare resource utilization by patients with treatment-refractory myasthenia gravis in England. J Med Econ. 2019;22(7):691–697
Linda Harris, Sophie Graham, Sharon MacLachlan, Alex Exuzides & Saiju Jacob
Pages: 864-865
Published online: 16 Jul 2021
CitationforReply: Re: Harris L, Graham S, MacLachlan S, et al. Healthcare resource utilization by patients with treatment-refractory myasthenia gravis in England. J Med Econ. 2019;22(7):691–697 | Full Text | References | PDF (233.8 KB) | EPUB
  • 819 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access
Article
Healthcare costs of patients with cancer stratified by Khorana score risk levels
Alok A. Khorana, Nicole M. Kuderer, Keith McCrae, Dejan Milentijevic, Guillaume Germain, François Laliberté, Sean D. MacKnight, Patrick Lefebvre, Gary H. Lyman & Michael B. Streiff
Pages: 866-873
Published online: 14 Jul 2021
AbstractforHealthcare costs of patients with cancer stratified by Khorana score risk levels | Full Text | References | PDF (1.5 MB) | EPUB
  • 1964 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access
Article
Cost-effectiveness analysis of anti–IL-5 therapies of severe eosinophilic asthma in Spain
Francisco Javier González-Barcala, Xavier Muñoz-Gall, Esther Mariscal, Andrea García, Shibing Yang, Gijs van de Wetering & José Luis Izquierdo-Alonso
Pages: 874-882
Published online: 14 Jul 2021
AbstractforCost-effectiveness analysis of anti–IL-5 therapies of severe eosinophilic asthma in Spain | Full Text | References | PDF (1 MB) | EPUB | Supplemental
  • 3243 Views
  • 7 CrossRef citations
  • 0Altmetric
Open Access
Article
Cost-effectiveness of a novel hybrid closed-loop system compared with continuous subcutaneous insulin infusion in people with type 1 diabetes in the UK
Stéphane Roze, Maria Ida Buompensiere, Zeynep Ozdemir, Simona de Portu & Ohad Cohen
Pages: 883-890
Published online: 16 Jul 2021
AbstractforCost-effectiveness of a novel hybrid closed-loop system compared with continuous subcutaneous insulin infusion in people with type 1 diabetes in the UK | Full Text | References | PDF (797.9 KB) | EPUB
  • 3324 Views
  • 8 CrossRef citations
  • 0Altmetric
Open Access
In Reply to Xue W, Ribalov R, Zhou Z-Y, et al. Re: Ganz ML, Chavan A, Dhanda R, et al. Cost-effectiveness of valbenazine compared with deutetrabenazine for the treatment of tardive dyskinesia. J Med Econ. 2021;24(1):103–113
Michael Serbin, Charles Yonan & Michael L. Ganz
Pages: 891-892
Published online: 19 Jul 2021
CitationforIn Reply to Xue W, Ribalov R, Zhou Z-Y, et al. Re: Ganz ML, Chavan A, Dhanda R, et al. Cost-effectiveness of valbenazine compared with deutetrabenazine for the treatment of tardive dyskinesia. J Med Econ. 2021;24(1):103–113 | Full Text | References | PDF (555.1 KB) | EPUB
  • 1185 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access
Article
Reassessing the cost-effectiveness of nivolumab for the treatment of renal cell carcinoma based on mature survival data, updated safety and lower comparator price
Hansoo Kim, Stephen Goodall & Danny Liew
Pages: 893-899
Published online: 29 Jul 2021
AbstractforReassessing the cost-effectiveness of nivolumab for the treatment of renal cell carcinoma based on mature survival data, updated safety and lower comparator price | Full Text | References | PDF (1 MB) | EPUB | Supplemental
  • 1640 Views
  • 1 CrossRef citations
  • 0Altmetric
Open Access
Article
Real-world migraine-related healthcare resource utilization and costs associated with improved vs. worsened/stable migraine: a panel-based chart review in France, Germany, Italy, and Spain
Pamela Vo, Elyse Swallow, Eric Wu, Miriam L. Zichlin, Noah Katcher, Monika Maier-Peuschel, Mariantonietta Naclerio, Daniela Ritrovato, Santosh Tiwari, Parth Joshi & Matias Ferraris
Pages: 900-907
Published online: 03 Aug 2021
AbstractforReal-world migraine-related healthcare resource utilization and costs associated with improved vs. worsened/stable migraine: a panel-based chart review in France, Germany, Italy, and Spain | Full Text | References | PDF (1.1 MB) | EPUB | Supplemental
  • 1859 Views
  • 2 CrossRef citations
  • 0Altmetric
Open Access
Brief Report
Continuing trends in U.S. brand-name and generic drug competition
Henry Grabowski, Genia Long, Richard Mortimer & Mehmet Bilginsoy
Pages: 908-917
Published online: 02 Aug 2021
AbstractforContinuing trends in U.S. brand-name and generic drug competition | Full Text | References | PDF (1.6 MB) | EPUB
  • 9622 Views
  • 2 CrossRef citations
  • 0Altmetric
Open Access
Article
Quantifying spillover benefits in value assessment: a case study of increased graft survival on the US kidney transplant waitlist
Syvart Dennen, Oliver Díaz Espinosa, Kelly Birch, Jennifer Cai, Jennifer C. Sung, Paula G. P. Machado & Jason Shafrin
Pages: 918-928
Published online: 10 Aug 2021
AbstractforQuantifying spillover benefits in value assessment: a case study of increased graft survival on the US kidney transplant waitlist | Full Text | References | PDF (1.8 MB) | EPUB | Supplemental
  • 1349 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access
Correction
Correction
Page: 929
Published online: 13 Aug 2021
CitationforCorrection | Full Text | PDF (105 KB) | EPUB
  • 613 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access
Article
Health care resource utilization and treatment variability in the care of patients with advanced or metastatic colorectal or gastric cancer
Lisa M. Hess, Yajun Emily Zhu, Yun Fang & Astra M. Liepa
Pages: 930-938
Published online: 10 Aug 2021
AbstractforHealth care resource utilization and treatment variability in the care of patients with advanced or metastatic colorectal or gastric cancer | Full Text | References | PDF (1 MB) | EPUB
  • 2013 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access
Article
Comparative economic outcomes in patients with focal seizures initiating eslicarbazepine acetate versus brivaracetam as their first adjunctive ASD
Darshan Mehta, Matthew Davis, Andrew J. Epstein, Brian Wensel, Todd Grinnell, Andrew Thach & G. Rhys Williams
Pages: 939-948
Published online: 09 Aug 2021
AbstractforComparative economic outcomes in patients with focal seizures initiating eslicarbazepine acetate versus brivaracetam as their first adjunctive ASD | Full Text | References | PDF (1.9 MB) | EPUB | Supplemental
  • 2281 Views
  • 1 CrossRef citations
  • 0Altmetric
Open Access
Article
Comparative efficacy, safety, and cost-effectiveness of abobotulinumtoxinA and onabotulinumtoxinA in children with upper limb spasticity: a systematic literature review, indirect treatment comparison, and economic evaluation
N. Danchenko, K. M. Johnston, K. Haeussler & J. Whalen
Pages: 949-961
Published online: 11 Aug 2021
AbstractforComparative efficacy, safety, and cost-effectiveness of abobotulinumtoxinA and onabotulinumtoxinA in children with upper limb spasticity: a systematic literature review, indirect treatment comparison, and economic evaluation | Full Text | References | PDF (1.7 MB) | EPUB | Supplemental
  • 2409 Views
  • 2 CrossRef citations
  • 0Altmetric
Open Access
Article
Economic burden of congenital athymia in the United States for patients receiving supportive care during the first 3 years of life
Cathleen Collins, Julie J. Kim-Chang, Elena Hsieh, Abigail Silber, Matthew O’Hara, Sarah Kulke & Megan A. Cooper
Pages: 962-971
Published online: 12 Aug 2021
AbstractforEconomic burden of congenital athymia in the United States for patients receiving supportive care during the first 3 years of life | Full Text | References | PDF (1.8 MB) | EPUB | Supplemental
  • 2542 Views
  • 1 CrossRef citations
  • 0Altmetric
Open Access
Article
Payer budget impact of an artificial intelligence in vitro diagnostic to modify diabetic kidney disease progression
Manasi Datar, William Burchenal, Michael J. Donovan, Steven G. Coca, Elaine Wang & Thomas F. Goss
Pages: 972-982
Published online: 17 Aug 2021
AbstractforPayer budget impact of an artificial intelligence in vitro diagnostic to modify diabetic kidney disease progression | Full Text | References | PDF (1.4 MB) | EPUB | Supplemental
  • 3882 Views
  • 3 CrossRef citations
  • 0Altmetric
Open Access
Article
The burden of skeletal-related events in four Latin American countries: Argentina, Brazil, Colombia, and Mexico
Javier Garcia Perlaza, Rima Aziziyeh, Anna Zhou, Vitor De Sousa Barbosa, Jenny Amaya, Joaquin Caporale, Monica Elena Alva, Juan Forero, Straus Tanaka, Gaurav Suri & David Garcia
Pages: 983-992
Published online: 17 Aug 2021
AbstractforThe burden of skeletal-related events in four Latin American countries: Argentina, Brazil, Colombia, and Mexico | Full Text | References | PDF (1.1 MB) | EPUB | Supplemental
  • 1854 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access
Article
Impact of liposomal bupivacaine and provider choice on opioid use and service outcomes in Medicare outpatient surgical patients
Allen Dobson, Alex Hartzman, Christopher Surfield & Joan E. DaVanzo
Pages: 993-1001
Published online: 18 Aug 2021
AbstractforImpact of liposomal bupivacaine and provider choice on opioid use and service outcomes in Medicare outpatient surgical patients | Full Text | References | PDF (878.7 KB) | EPUB | Supplemental
  • 1369 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access
Article
Cost of microvascular complications in people with diabetes from a public healthcare perspective: a retrospective database study in Brazil
Guilherme Silva Julian, Lilian Mariana Accetturi Pititto, Nino Miresashvili, Julie Broe Honoré, Raquel Cristina Lopes Assis Coelho & Daniel Campos
Pages: 1002-1010
Published online: 23 Aug 2021
AbstractforCost of microvascular complications in people with diabetes from a public healthcare perspective: a retrospective database study in Brazil | Full Text | References | PDF (1.1 MB) | EPUB | Supplemental
  • 1612 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access
Article
Cost, healthcare utilization, and outcomes of antibody-mediated rejection in kidney transplant recipients in the US
Allyson Hart, David Zaun, Robbin Itzler, David Schladt, Ajay Israni & Bertram Kasiske
Pages: 1011-1017
Published online: 18 Aug 2021
AbstractforCost, healthcare utilization, and outcomes of antibody-mediated rejection in kidney transplant recipients in the US | Full Text | References | PDF (1.1 MB) | EPUB
  • 2055 Views
  • 2 CrossRef citations
  • 0Altmetric
Open Access
Article
Economic implications of the modern treatment paradigm of glioblastoma: an analysis of global cost estimates and their utility for cost assessment
Nicholas J. Goel, Cylaina E. Bird, William H. Hicks & Kalil G. Abdullah
Pages: 1018-1024
Published online: 24 Aug 2021
AbstractforEconomic implications of the modern treatment paradigm of glioblastoma: an analysis of global cost estimates and their utility for cost assessment | Full Text | References | PDF (775 KB) | EPUB | Supplemental
  • 5207 Views
  • 9 CrossRef citations
  • 0Altmetric
Open Access
Article
Healthcare utilization and expenditures associated with hyperkalemia management: a retrospective study of Medicare Advantage patients
Nihar R. Desai, Paula J. Alvarez, Ladan Golestaneh, Steven D. Woods, Steven G. Coca & Christopher G. Rowan
Pages: 1025-1036
Published online: 26 Aug 2021
AbstractforHealthcare utilization and expenditures associated with hyperkalemia management: a retrospective study of Medicare Advantage patients | Full Text | References | PDF (3 MB) | EPUB | Supplemental
  • 2777 Views
  • 2 CrossRef citations
  • 0Altmetric
Open Access
Article
An economic evaluation of vagus nerve stimulation as an adjunctive treatment to anti-seizure medications for the treatment of drug-resistant epilepsy in England
Christopher Raspin, Rohit Shankar, Francesca Barion, Vicki Pollit, Joanna Murphy, Laura Sawyer & Vanessa Danielson
Pages: 1037-1051
Published online: 31 Aug 2021
AbstractforAn economic evaluation of vagus nerve stimulation as an adjunctive treatment to anti-seizure medications for the treatment of drug-resistant epilepsy in England | Full Text | References | PDF (2.2 MB) | EPUB | Supplemental
  • 3239 Views
  • 5 CrossRef citations
  • 0Altmetric
Open Access
Article
Cost of hemophilia A in Turkey: an economic disease burden analysis
Simten Malhan, Ergün Öksüz, Bülent Antmen, Muhlis Cem Ar, Can Balkan & Kaan Kavaklı
Pages: 1052-1059
Published online: 30 Aug 2021
AbstractforCost of hemophilia A in Turkey: an economic disease burden analysis | Full Text | References | PDF (1.1 MB) | EPUB
  • 3404 Views
  • 3 CrossRef citations
  • 0Altmetric
Open Access
Article
Economic value of vaccines to address the COVID-19 pandemic: a U.S. cost-effectiveness and budget impact analysis
William V. Padula, Shreena Malaviya, Natalie M. Reid, Benjamin G. Cohen, Francine Chingcuanco, Jeromie Ballreich, Jonothan Tierce & G. Caleb Alexander
Pages: 1060-1069
Published online: 31 Aug 2021
AbstractforEconomic value of vaccines to address the COVID-19 pandemic: a U.S. cost-effectiveness and budget impact analysis | Full Text | References | PDF (1.1 MB) | EPUB | Supplemental
  • 13156 Views
  • 23 CrossRef citations
  • 0Altmetric
Open Access
Article
The IMPact of untReated nOn-Valvular atrial fibrillation on short-tErm clinical and economic outcomes in the US Medicare population: the IMPROVE-AF model
Matthew Sussman, Manuela Di Fusco, Charles Y. Tao, Jennifer D. Guo, John A. Gillespie, Mauricio Ferri, Nicholas Adair, Matthew S. Cato, Ilnaz Shirkhorshidian & Geoffrey D. Barnes
Pages: 1070-1082
Published online: 09 Sep 2021
AbstractforThe IMPact of untReated nOn-Valvular atrial fibrillation on short-tErm clinical and economic outcomes in the US Medicare population: the IMPROVE-AF model | Full Text | References | PDF (1.8 MB) | EPUB
  • 2173 Views
  • 1 CrossRef citations
  • 0Altmetric
Open Access
Editorial
Comprehensive value assessments for new pediatric pneumococcal conjugate vaccines
Tianyan Hu, Thomas Weiss, Goran Bencina, Kwame Owusu-Edusei & Tanaz Petigara
Pages: 1083-1086
Published online: 14 Sep 2021
AbstractforComprehensive value assessments for new pediatric pneumococcal conjugate vaccines | Full Text | References | PDF (631 KB) | EPUB
  • 1761 Views
  • 2 CrossRef citations
  • 0Altmetric
Open Access
Article
Real-life management of neovascular age-related macular degeneration (nAMD) in France: a nationwide observational study using retrospective claims data
Jean-François Korobelnik, Cécile Delcourt, Catherine Creuzot-Garcher, Asma Melaine, Jules Chassetuillier, Anne Lejeune, Stève Bénard & Laure Dupont-Benjamin
Pages: 1087-1097
Published online: 06 Sep 2021
AbstractforReal-life management of neovascular age-related macular degeneration (nAMD) in France: a nationwide observational study using retrospective claims data | Full Text | References | PDF (1.4 MB) | EPUB
  • 2735 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access
Article
Health and economic burden of invasive pneumococcal disease associated with 15-valent pneumococcal conjugate vaccine serotypes in children across eight European countries
Tianyan Hu, Thomas Weiss, Goran Bencina, Kwame Owusu-Edusei & Tanaz Petigara
Pages: 1098-1107
Published online: 14 Sep 2021
AbstractforHealth and economic burden of invasive pneumococcal disease associated with 15-valent pneumococcal conjugate vaccine serotypes in children across eight European countries | Full Text | References | PDF (1.3 MB) | EPUB | Supplemental
  • 2842 Views
  • 7 CrossRef citations
  • 0Altmetric
Open Access
Correction
Correction
Page: 1108
Published online: 15 Sep 2021
CitationforCorrection | Full Text | PDF (202.7 KB) | EPUB
  • 712 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access
Article
Determinants of market prices for drugs under Japan’s national health insurance
Hiroaki Mamiya & Ataru Igarashi
Pages: 1109-1114
Published online: 20 Sep 2021
AbstractforDeterminants of market prices for drugs under Japan’s national health insurance | Full Text | References | PDF (980.1 KB) | EPUB
  • 2517 Views
  • 1 CrossRef citations
  • 0Altmetric
Open Access
Article
Clinical and economic burden of obstructive hypertrophic cardiomyopathy in the United States
Sneha S. Jain, Sophia S. Li, Jipan Xie, Megan B. Sutton, Jennifer T. Fine, Jay M. Edelberg, Wei Gao, John A. Spertus & David J. Cohen
Pages: 1115-1123
Published online: 22 Sep 2021
AbstractforClinical and economic burden of obstructive hypertrophic cardiomyopathy in the United States | Full Text | References | PDF (1.4 MB) | EPUB | Supplemental
  • 4578 Views
  • 7 CrossRef citations
  • 0Altmetric
Open Access
Article
Cost-effectiveness of nivolumab monotherapy in the third-line treatment of small cell lung cancer
Caitlin Smare, Kiran Dave, Ariadna Juarez-Garcia, Pranav Abraham, John R. Penrod, D. Ross Camidge & Yong Yuan
Pages: 1124-1133
Published online: 30 Sep 2021
AbstractforCost-effectiveness of nivolumab monotherapy in the third-line treatment of small cell lung cancer | Full Text | References | PDF (1,000 KB) | EPUB | Supplemental
  • 3201 Views
  • 1 CrossRef citations
  • 0Altmetric
Open Access
Article
Modeling the optimal sequence of biologic therapies in plaque psoriasis in Spain
Alexander Egeberg, Anne Danø, Mikkel H. Pedersen, Anne Sohrt, Emma Borg & Jaime Notario
Pages: 1134-1142
Published online: 25 Sep 2021
AbstractforModeling the optimal sequence of biologic therapies in plaque psoriasis in Spain | Full Text | References | PDF (1.5 MB) | EPUB
  • 2729 Views
  • 4 CrossRef citations
  • 0Altmetric
Open Access
Article
Variation in access to hemophilia A treatments in the United States
Nikoletta M. Margaretos, Anisha M. Patel, Ari D. Panzer, Rachel C. Lai, Jennifer Whiteley & James D. Chambers
Pages: 1143-1148
Published online: 04 Oct 2021
AbstractforVariation in access to hemophilia A treatments in the United States | Full Text | References | PDF (773.5 KB) | EPUB
  • 1639 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access
Article
Budget impact of optimizing rifaximin-α use for the prevention of recurrent hepatic encephalopathy in The Netherlands
Lisa Aniek de Jong, Alexander Victor van Schoonhoven, Hinko Stephan Hofstra, Maarten Jacobus Postma & Bart van Hoek
Pages: 1149-1163
Published online: 09 Oct 2021
AbstractforBudget impact of optimizing rifaximin-α use for the prevention of recurrent hepatic encephalopathy in The Netherlands | Full Text | References | PDF (2.6 MB) | EPUB | Supplemental
  • 1985 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access
Article
Cost-minimization analysis of biweekly dosing of cetuximab and FOLFIRI compared with panitumumab and FOLFOX for first-line treatment of patients with KRAS wild-type metastatic colorectal cancer in the United States
Wambui Grace Gathirua-Mwangi, Harsheen Sethi, Manuel Geroy Afable, Devarshi Bhattacharyya & Taha Khan
Pages: 1164-1172
Published online: 14 Oct 2021
AbstractforCost-minimization analysis of biweekly dosing of cetuximab and FOLFIRI compared with panitumumab and FOLFOX for first-line treatment of patients with KRAS wild-type metastatic colorectal cancer in the United States | Full Text | References | PDF (1.2 MB) | EPUB
  • 3095 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access
Article
Patient out-of-pocket costs for suspicious pulmonary nodule biopsy in lung cancer patients
Feibi Zheng, James Lavin & J. Michael Sprafka
Pages: 1173-1177
Published online: 18 Oct 2021
AbstractforPatient out-of-pocket costs for suspicious pulmonary nodule biopsy in lung cancer patients | Full Text | References | PDF (738.3 KB) | EPUB
  • 2349 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access
Article
Cost analysis of the impact of caplacizumab in the treatment of acquired thrombotic thrombocytopenic purpura from a US hospital perspective
Laurence Pollissard, Brian I. Leinwand, Marie Fournier & Huy P. Pham
Pages: 1178-1184
Published online: 23 Oct 2021
AbstractforCost analysis of the impact of caplacizumab in the treatment of acquired thrombotic thrombocytopenic purpura from a US hospital perspective | Full Text | References | PDF (925.1 KB) | EPUB | Supplemental
  • 2450 Views
  • 1 CrossRef citations
  • 0Altmetric
Open Access
Article
Number needed to treat analysis applied to pembrolizumab plus chemotherapy for first-line treatment of non-squamous non-small cell lung cancer
Luciano Paladini, Cássia Rita Pereira da Veiga, Érica Cerqueira, Laura Chabrol Haas, Márcia Datz Abadi & Clarissa Seródio Baldotto
Pages: 1185-1193
Published online: 27 Oct 2021
AbstractforNumber needed to treat analysis applied to pembrolizumab plus chemotherapy for first-line treatment of non-squamous non-small cell lung cancer | Full Text | References | PDF (1.2 MB) | EPUB | Supplemental
  • 3081 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access
Article
Economic burden to commercial payers of young adults with schizophrenia in Colorado
Jacqueline Pesa, Charmi Patel, David Rotter, Eros Papademetriou, Ravi Potluri & Carmela Benson
Pages: 1194-1203
Published online: 16 Nov 2021
AbstractforEconomic burden to commercial payers of young adults with schizophrenia in Colorado | Full Text | References | PDF (1.9 MB) | EPUB | Supplemental
  • 1159 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access
Article
Retrospective analysis of adherence to HIV treatment and healthcare utilization in a commercially insured population
Julie Priest, Rachel H. Bhak, Maral Dersarkissian, Alan Oglesby, Colin Kunzweiler, Ellie Fuqua, Suna Park, Mei Sheng Duh & Cindy Garris
Pages: 1204-1211
Published online: 07 Nov 2021
AbstractforRetrospective analysis of adherence to HIV treatment and healthcare utilization in a commercially insured population | Full Text | References | PDF (818.8 KB) | EPUB
  • 1602 Views
  • 2 CrossRef citations
  • 0Altmetric
Open Access
Article
Hospitalization risk in pediatric patients with bipolar disorder treated with lurasidone vs. other oral atypical antipsychotics: a real-world retrospective claims database study
Aditi Kadakia, Carole Dembek, Yi Liu, Christopher Dieyi & G. Rhys Williams
Pages: 1212-1220
Published online: 09 Nov 2021
AbstractforHospitalization risk in pediatric patients with bipolar disorder treated with lurasidone vs. other oral atypical antipsychotics: a real-world retrospective claims database study | Full Text | References | PDF (1 MB) | EPUB
  • 2207 Views
  • 1 CrossRef citations
  • 0Altmetric
Open Access
Article
Phase-specific and lifetime economic burden of cervical cancer and endometrial cancer in a commercially insured United States population
Ruchit Shah, Shelby Corman, Anuj Shah, Nehemiah Kebede & Chizoba Nwankwo
Pages: 1221-1230
Published online: 09 Nov 2021
AbstractforPhase-specific and lifetime economic burden of cervical cancer and endometrial cancer in a commercially insured United States population | Full Text | References | PDF (1.8 MB) | EPUB
  • 1906 Views
  • 3 CrossRef citations
  • 0Altmetric
Open Access
Article
Clinical implications and cost-effectiveness analysis of rivaroxaban in patients with coronary artery disease or peripheral arterial disease in the Netherlands
J. A. Spoorendonk, J.-B. Briere, K. Bowrin, A. Millier, M. Coppens, S. Tempelaar & B. Verheggen
Pages: 1231-1239
Published online: 11 Nov 2021
AbstractforClinical implications and cost-effectiveness analysis of rivaroxaban in patients with coronary artery disease or peripheral arterial disease in the Netherlands | Full Text | References | PDF (1.1 MB) | EPUB
  • 2086 Views
  • 1 CrossRef citations
  • 0Altmetric
Open Access
Article
Estimating hospital inpatient cost-savings with sucroferric oxyhydroxide in patients on chronic hemodialysis in five European countries: a cost analysis
Jose Antonio Herrero, Mario Salomone, Antonio Ramirez de Arellano, Thilo Schaufler & Sebastian Walpen
Pages: 1240-1247
Published online: 11 Nov 2021
AbstractforEstimating hospital inpatient cost-savings with sucroferric oxyhydroxide in patients on chronic hemodialysis in five European countries: a cost analysis | Full Text | References | PDF (749.2 KB) | EPUB | Supplemental
  • 1771 Views
  • 1 CrossRef citations
  • 0Altmetric
Open Access
Article
Evaluation of COVID-19 vaccine breakthrough infections among immunocompromised patients fully vaccinated with BNT162b2
Manuela Di Fusco, Mary M. Moran, Alejandro Cane, Daniel Curcio, Farid Khan, Deepa Malhotra, Andy Surinach, Amanda Miles, David Swerdlow, John M. McLaughlin & Jennifer L. Nguyen
Pages: 1248-1260
Published online: 30 Nov 2021
AbstractforEvaluation of COVID-19 vaccine breakthrough infections among immunocompromised patients fully vaccinated with BNT162b2 | Full Text | References | PDF (1.8 MB) | EPUB | Supplemental
  • 17533 Views
  • 23 CrossRef citations
  • 0Altmetric
Open Access
Article
Cost-effectiveness of high dose versus adjuvanted trivalent influenza vaccines in England and Wales
Richard Mattock, Ilana Gibbons, Joe Moss, Stuart Mealing, Nathalie Largeron, Stuart Carroll & Fabián P. Alvarez
Pages: 1261-1271
Published online: 16 Nov 2021
AbstractforCost-effectiveness of high dose versus adjuvanted trivalent influenza vaccines in England and Wales | Full Text | References | PDF (1.4 MB) | EPUB | Supplemental
  • 2597 Views
  • 1 CrossRef citations
  • 0Altmetric
Open Access
Article
Identifying chronic disease patients using predictive algorithms in pharmacy administrative claims: an application in rheumatoid arthritis
Ervant J. Maksabedian Hernandez, Isabelle Tingzon, Lorenzo Ampil & Jessica Tiu
Pages: 1272-1279
Published online: 16 Nov 2021
AbstractforIdentifying chronic disease patients using predictive algorithms in pharmacy administrative claims: an application in rheumatoid arthritis | Full Text | References | PDF (1.6 MB) | EPUB
  • 1611 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access
Article
Evaluating the burden of pruritus due to atopic dermatitis in Japan by patient-reported outcomes
Hiroyuki Murota, Yuta Koike, Kanako Ishii, Brian M. Calimlim, Maja Ludwikowska, Mondher Toumi & Isao Kawaguchi
Pages: 1280-1289
Published online: 24 Nov 2021
AbstractforEvaluating the burden of pruritus due to atopic dermatitis in Japan by patient-reported outcomes | Full Text | References | PDF (1.6 MB) | EPUB | Supplemental
  • 2714 Views
  • 1 CrossRef citations
  • 0Altmetric
Open Access
Article
Respiratory morbidity, healthcare resource use, and cost burden associated with extremely preterm birth in The Netherlands
Eline Houben, Csaba Siffel, Jetty Overbeek, Fernie Penning-van Beest, Victoria Niklas & Sujata P. Sarda
Pages: 1290-1298
Published online: 19 Nov 2021
AbstractforRespiratory morbidity, healthcare resource use, and cost burden associated with extremely preterm birth in The Netherlands | Full Text | References | PDF (1.9 MB) | EPUB | Supplemental
  • 1381 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access
Article
Health care resource use, short-term disability days, and costs associated with states of persistence on antidepressant lines of therapy
Dominic Pilon, Swapna Karkare, Maryia Zhdanava, John J. Sheehan, Aurélie Côté-Sergent, Aditi Shah, Oliver J. Lopena, Patrick Lefebvre, Kruti Joshi & Leslie Citrome
Pages: 1299-1308
Published online: 24 Nov 2021
AbstractforHealth care resource use, short-term disability days, and costs associated with states of persistence on antidepressant lines of therapy | Full Text | References | PDF (1.7 MB) | EPUB | Supplemental
  • 1484 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access
Article
Budget impact analysis of the DiviTum TKa assay in postmenopausal women with hormone receptor positive metastatic breast cancer
Josh J. Carlson, Gregory F. Guzauskas, Robert A. Dann & Scott D. Ramsey
Pages: 1309-1317
Published online: 30 Nov 2021
AbstractforBudget impact analysis of the DiviTum TKa assay in postmenopausal women with hormone receptor positive metastatic breast cancer | Full Text | References | PDF (1.2 MB) | EPUB
  • 1887 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access
Article
Hospitalization costs with degludec versus glargine U100 for patients with type 2 diabetes at high cardiovascular risk: Canadian costs applied to SAEs from a randomized outcomes trial
Jean-Eric Tarride, Mansoor Husain, Andreas Andersen, Jens Gundgaard, Maria Luckevich, Thomas Mark, Lily Wagner & Thomas R. Pieber
Pages: 1318-1326
Published online: 24 Nov 2021
AbstractforHospitalization costs with degludec versus glargine U100 for patients with type 2 diabetes at high cardiovascular risk: Canadian costs applied to SAEs from a randomized outcomes trial | Full Text | References | PDF (873.9 KB) | EPUB | Supplemental
  • 1338 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access
Article
Healthcare utilization and cost burden of Huntington’s disease among Medicare beneficiaries in the United States
Alex Exuzides, Sheila R. Reddy, Eunice Chang, Jamie T. Ta, Anisha M. Patel, Caleb Paydar & George J. Yohrling
Pages: 1327-1336
Published online: 11 Dec 2021
AbstractforHealthcare utilization and cost burden of Huntington’s disease among Medicare beneficiaries in the United States | Full Text | References | PDF (1,017.6 KB) | EPUB
  • 2796 Views
  • 5 CrossRef citations
  • 0Altmetric
Open Access
Article
Costs of treatment change following first-line somatostatin analog monotherapy among patients with neuroendocrine tumors
Bernard Tawfik, David Ray, Meghan Moynihan & Nicole Princic
Pages: 1337-1345
Published online: 30 Nov 2021
AbstractforCosts of treatment change following first-line somatostatin analog monotherapy among patients with neuroendocrine tumors | Full Text | References | PDF (1.6 MB) | EPUB | Supplemental
  • 1271 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access
Correction
Correction
Page: 1346
Published online: 23 Dec 2021
CitationforCorrection | Full Text | PDF (93.2 KB) | EPUB
  • 543 Views
  • 0 CrossRef citations
  • 0Altmetric
Free Access

Explore articles

Explore the most recently published articles

Impact of COVID-19 on work loss in the United States- A retrospective database analysis
Jennifer Judy et al.
Article | Published online: 18 Jul 2024
Open Access
Cost analysis of patiromer versus sodium zirconium cyclosilicate for the treatment of hyperkalemia in Spain and the UK
Antonio Ramirez de Arellano et al.
Article | Published online: 18 Jul 2024
Open Access
The clinical and economic burdens of metabolic dysfunction-associated steatohepatitis
Michael Charlton et al.
Article | Published online: 17 Jul 2024
Open Access
Budget impact analysis of the novel PD-1 inhibitor toripalimab versus pembrolizumab in recurrent or metastatic nasopharyngeal carcinoma
Ivo Abraham et al.
Article | Published online: 17 Jul 2024
Open Access
View all latest articles